Insurers navigate risk of two-thirds weight regain with GLP-1 medications: Swiss Re
Reinsurance News - Apr 16, 2025
Insurance companies face a growing challenge as they adapt to the rise of GLP-1 receptor agonists, such as Ozempic and Wegovy, which have proven effective in managing weight and improving obesity-related health conditions. Swiss Re, a provider of reinsurance and insurance solutions, highlights the i...
Recommended Articles
Posted: Apr 16, 2026
Capgemini Research Institute, the research division of the Capgemini, has published the report Physi...
Posted: Apr 16, 2026
Beazley, a large specialist insurer, has announced plans to establish a new Marine War insurance con...
Posted: Apr 16, 2026
John Doyle, President and Chief Executive Officer (CEO) of global insurance and reinsurance broking...